CHI3L1 and neoplasm: They also demonstrate an additive antitumor response in melanoma lung metastasis with simultaneous treatment with individual antibodies against CHI3L1 and CTLA-4 and synergistic CD8+ cytotoxic T cell-mediated tumor cell death with bispecific antibodies that target these two moieties.